Mechanism of anticonvulsant action of valproate.
D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D004827:Epilepsy / Q000188:drug therapy; D006207:Half-Life; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D001523:Mental Disorders / Q000188:drug therapy; D051379:Mice; D009069:Movement Disorders / Q000188:drug therapy; D018377:Neurotransmitter Agents / Q000378:metabolism; D011485:Protein Binding; D011817:Rabbits; D051381:Rats; D014635:Valproic Acid / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D018377:Neurotransmitter Agents; D001224:Aspartic Acid; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid